Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15000 participants
INTERVENTIONAL
2003-01-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Doula Combined Latent Phrase Epidural Analgesia in Primiparous Women
NCT00664118
Comparison of Combined Spinal-epidural Analgesia Versus Epidural Analgesia for Pain Management During Labor
NCT03600272
Intravenous Remifentanil for Labor Analgesia
NCT00710086
Spinal Analgesia as Fast Track Painless Labor
NCT05271760
Neuraxial Versus Systemic Analgesia for Latent Phase Labor Effect on Rate of Operative Delivery
NCT00380978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
I
Active phrase analgesia
Active phrase epidural analgesia
Continuous epidural analgesia with sufentanil plus ropivacaine
II
Latent phrase analgesia
Latent phrase epidural analgesia
Continuous epidural analgesia with sufentanil plus ropivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active phrase epidural analgesia
Continuous epidural analgesia with sufentanil plus ropivacaine
Latent phrase epidural analgesia
Continuous epidural analgesia with sufentanil plus ropivacaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Required labor analgesia
* Chinese.
Exclusion Criteria
* Failed to performing epidural catheterization
* Organic dysfunction
* Contraindications for epidural analgesia.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nanjing Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
XiaoFeng Shen, MD
Role: STUDY_DIRECTOR
Nanjing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanjing Maternal and Child Health Care Hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wang F, Shen X, Guo X, Peng Y, Gu X; Labor Analgesia Examining Group. Epidural analgesia in the latent phase of labor and the risk of cesarean delivery: a five-year randomized controlled trial. Anesthesiology. 2009 Oct;111(4):871-80. doi: 10.1097/ALN.0b013e3181b55e65.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCH03552
Identifier Type: -
Identifier Source: secondary_id
NMU-69714-14XS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.